Sorrento TherapeuticsSRNE
13F holders, Q1 2026 (March 31)4holders −1
1new positions
2sold out
$0.00avg. 13F price*
At the end of Q1 2026, 4 institutions reported holding Sorrento Therapeutics Inc. (SRNE) in their 13F filings, down 1 from Q4 2025. 1 opened new positions and 2 sold out. The largest holders were VSM Wealth Advisory, LLC ($363), Huntington National Bank ($16) and Oakworth Capital, Inc. ($1).
- Company
- Sorrento Therapeutics Inc.
- CUSIP
- 83587F202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $363 |
| Exits | 2 | $67 |
All 13F filers, Q4 2025 → Q1 2026: 110,100 shares bought and 25,655 shares sold, net +84,445 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| VSM Wealth Advisory, LLC | 0.00% | New | 110,100 | $363 |
| Huntington National Bank | 0.00% | No change | 5,001 | $16 |
| Oakworth Capital, Inc. | 0.00% | No change | 350 | $1 |
| Financial Gravity Asset Management, Inc. | 0.00% | No change | 18 | $0 |
"% of holder's portfolio" is SRNE's weight in each manager's 13F, not the share of Sorrento Therapeutics Inc. the manager owns.